Former Editorial Board

Joachim G. Aerts, MD, PhD

Department of Pulmonary Diseases, Amphia Hospital, Breda, The Netherlands; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Myung-Ju Ahn, MD

Professor Division of Hemato-Oncology Department of Medicine Sungkyunkwan University School of Medicine Seoul, Korea

Luca Ampollini, MD, PhD

Thoracic Surgery, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy

Oscar Arrieta, MD, MSc

Thoracic Oncology Unit, Instituto Nacional de Cancerología de México (INCan), Mexico

David Ball, MB, BS, MD, FRANZCR

Deputy Director of Radiation Oncology & Cancer Imaging, Chair of Lung Service, Peter MacCallum Cancer Centre, Melbourne, Australia

Fiona Blackhall

Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Institute of Cancer Sciences, University of Manchester, Manchester, UK

Michael Boyer, MD

Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Elisabeth Brambilla

Centre Hospitalier Universitaire de Grenoble, Département d'Anatomie et Cytologie Pathologiques, Grenoble, France

Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; Medical Oncology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy

Lauren Byers, MD

Associate Professor, Department of Thoracic/Head & Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA

Federico Cappuzzo, MD

Director of Medical Oncology, AUSL della Romagna-Ravenna, Italy

Jianhua Chang

Department of Oncology, Cancer Hospital Affiliated to Fudan University, Shanghai, China

Aadel A. Chaudhuri, MD, PhD

Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA

Jun Chen

Department of Medical Oncology, The Second Affiliated Hospital, Dalian Medical University, Dalian, China

Chang Chen, MD, PhD

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Caroline Chiles

Department of Radiology, Wake Forest University Health Sciences Center, Winston-Salem, North Carolina, USA

William Chi-shing Cho

Queen Elizabeth Hospital, Hong Kong, China

J. Isabelle Choi

Radiation Oncology, California Protons Cancer Therapy Center, San Diego, California, USA

Jin-Haeng Chung

Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea

Wendy A. Cooper

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Daniel B. Costa

Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Sanja Dacic, MD, PhD

Department of Pathology, University of Pittsburgh, PUH C-608, 200 Lothrop Street, Pittsburgh, PA 15213, USA

Xiaorong Dong

Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Yun Fan

Department of Thoracic Oncology, Zhejiang Tumor Hospital, Hangzhou, Zhejiang, China

Wenfeng Fang

Department of Internal Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

Anna F. Farago, MD, PhD

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA

John K. Field, MA, PhD, BDS, FRCPath

Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Liverpool, UK

Shirish Madhav Gadgeel, MD

Professor, Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, USA

Justin F. Gainor

Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA

David R. Gandara, MD

University of California Davis Comprehensive Cancer Center, Sacramento, California, USA

Adi F. Gazdar

Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA; Departments of Pathology, UT Southwestern Medical Center, Dallas, TX, USA

Akihiko Gemma, MD (Medical Oncology)

Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, President of Nippon Medical School, Tokyo, Japan

Vassilis Georgoulias MD, PhD

Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Greece; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece

Jonathan W. Goldman, MD

Associate Professor, UCLA Hematology & Oncology Associate Director of Drug Development Director of Clinical Trials in Thoracic Oncology, California, USA

Peter Goldstraw, MD, FRCS

Academic Department of Thoracic Surgery, Royal Brompton Hospital, Imperial College London, London, UK

Cesare Gridelli, MD

Division of Medical Oncology, ‘S. G. Moscati’ Hospital, Avellino, Italy

Renhua Guo

Department of Oncology, Jiangsu Provincial People's Hospital, Jiangsu, China

Yong Guo

Department of Oncology, First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Zhejiang, China

Balazs Halmos, MD

Professor of Clinical Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, New York, USA

Zhengxiang Han

Department of Oncology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, China

Takeshi Hanagiri, MD, PhD

Second Department of Surgery, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan

Samir Hanash, MD, PhD

The University of Texas MD Anderson Cancer Center, Houston, Texas; Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer; Evelyn & Sol Rubenstein Distinguished Chair for Cancer Prevention; Professor, Clinical Cancer Prevention-Research; Professor, Translational Molecular Pathology

Yayi He, MD, PhD

Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China

Chuong D. Hoang, MD

Section of Thoracic Surgery, National Institutes of Health, National Cancer Institute, Center for Cancer Research, and The Clinical Center, Bethesda, USA

Paul Hofman, MD, PhD

Université Côte d’Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Université Côte d’Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Team 4, Nice, France; Université Côte d’Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank, Nice, France

Maurizio V. Infante, MD

Head of Thoracic Surgery Dept. University and Hospital Trust, Verona, Italy

Da Jiang

Department of Oncology, the Fourth Affiliated Hospital of Hebei Medical University, Hebei, China

Xiao-dong Jiang, MD, PhD

Director of Oncology Department and Radiotherapy Centre, Chief Physician, No.1 People’s Hospital of Lianyungang City (3A), Jiangsu, China

Tao Jiang, PhD

Medical oncology, Shanghai Pulmonary Hospital, Thoracic Oncology Center, Tongji University School of Medicine, Shanghai, China

Kazuhiro Kakimi, MD, PhD

Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan Medical Sciences Innovation Hub Program, RIKEN, Tokyo, Japan

Gregory P. Kalemkerian, MD, FACP

Professor, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA

Niki Karachaliou, MD

Pangaea Biotech, USP Instituto Universitario Dexeus, Barcelona, Spain

Edward S. Kim, MD

Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA

Yoshihisa Kobayashi, MD, PhD

Department of Thoracic Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA

Takashi Kohno, PhD

Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan

Feng-Ming (Spring) Kong, MD, PhD, Fellow of American College of Radiology

Professor of Radiation Oncology and Medical and Molecular Genetics, Indiana University; Director of Clinical Research and Clinical Trial, Department of Radiation Oncology, Co-Leader of Thoracic Oncology Program, Melvin and Bren Simon Cancer Center, Indianapolis, USA

Alexander Sasha Krupnick, MD

Department of Surgery, University of Virginia, Charlottesville, Virginia, USA

Choon-Taek Lee, MD, PhD

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Bundang-Gu, Seongnam, Gyeonggi-do, Republic of Korea

Antonin Levy, MD, PhD (Radiation Oncology)

Department of Radiation Oncology, Gustave Roussy Cancer Centre, Villejuif, Université Paris-Saclay, France

Lu Li, MD

Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Ziming Li, MD, PhD

Deputy Director of Shanghai Lung Cancer Center. Shanghai Chest Hospital, Jiao Tong University School of Medicine, Shanghai, China

Xiaohua Liang

Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China

Ying Liang, MD, PhD

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Yang Ling, MD

Changzhou Cancer Hospital, Affiliated of Soochow University, Changzhou, China

Chunling Liu

Department of Respiratory Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China

Jiang Liu

Department of Oncology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China

Jiwei Liu

Department of Oncology, First Affiliated Hospital of Dalian Medical Universtiy, Dalian, China

Hongbing Liu, MD, PhD

Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

William W. Lockwood, MD, PhD

Integrative Oncology Department, BC Cancer Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada

You Lu

Department of Thoracic Oncology, West China Hospital of Sichuan University, Sichuan, China

Tangfeng Lv

Department of Respiratory Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China

Zhiyong Ma

Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China

Patrick C. Ma, MD, MS

WVU Cancer Institute, West Virginia University, Morgantown, West Virginia, USA

David MacPherson, PhD

Fred Hutchinson Cancer Research Center, Division of Human Biology, Seattle, Washington, USA

Jyoti Malhotra, MD, MPH

Assistant Professor, Medical Oncology Co-leader, Thoracic Oncology Disease Specific Group Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA

Hirva Mamdani, MD

Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan, USA

Christian Manegold, MD

Department of Surgery, Interdisciplinary Thoracic Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany

Yukinori Matsuo, MD, PhD

Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Giulio Metro, MD

Department of Medical Oncology, Santa Maria della Misericordia Hospital, AOU di Perugia, Italy

John D. Minna, M.D.

Director of the Hamon Center for Therapeutic Oncology Research, Professor of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA

Tetsuya Mitsudomi, MD

Department of Surgery, Division of Thoracic Surgery, Kinki University Faculty of Medicine, Osaka-Sayama, Japan

James L. Mulshine, MD

Department of Internal Medicine, Associate Provost for Research and Vice President, Rush University, Chicago, USA

Yasuhiko Nishioka, MD, PhD

Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan

Nicola Normanno, MD

Cell Biology and Biotherapy Unit, National Cancer Institute "Pascale Foundation," Institute of Hospitalization and Scientific Care (IRCCS), Naples, Italy

Silvia Novello, MD, PhD

Oncology Department-Thoracic Oncology Unit, AOU San Luigi, University of Turin, Italy

Raymond U. Osarogiagbon, MBBS, FACP

Multidisciplinary Thoracic Oncology Program, Baptist Centers for Cancer Care, Memphis, TN, USA

Taofeek K. Owonikoko, MD, PhD

Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA

Kenneth O’Byrne

Consultant Medical Oncologist, Princess Alexandra Hospital (PAH)/Queensland University of Technology, Brisbane, Australia

Joshua D. Palmer, MD

Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA

Yueyin Pan

Department of Oncology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

Luis Paz-Ares, MD, PhD

Chair of the Medical Oncology Department at the Hospital Universitario 12 de Octubre Associate Professor at the Universidad Complutense de Madrid; Head of the Lung Cancer Unit at the CNIO (Spanish National Cancer Research Center) President of ASEICA (Spanish Association of Cancer Research), Madrid, Spain

Nathan A. Pennell, MD, PhD

Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA

Helmut H. Popper, MD

Prof. of Pathology, Department of Pathology, Medical University of Graz, Austria

Luis E. Raez, MD, FACP, FCCP

Chief, Hematology/Oncology & Medical Director of Memorial Cancer Institute (MCI) Director, Thoracic Oncology Program, Florida, USA

Suresh S. Ramalingam, MD

Winship Cancer Institute, Emory University, Atlanta, Georgia, USA

Neal E. Ready, MD, PhD

Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina, USA

Jordi Remon, MD

Medical Oncology Department, Centro Integral Oncología Clara Campal Barcelona-HM Delfos, Barcelona, Spain

Christian D. Rolfo

Professor in Oncology Antwerp University Hospital, Belgium

Giulio Rossi, MD, PhD

Doctor Rossi is currently Director of the Pathology Units, Azienda USL della Romagna, Hospital St. Maria delle Croci (Ravenna, Italy) and Hospital “Degli Infermi” (Rimini, Italy)

Antonio Rossi, Sr. M.D.

Oncology Centre of Excellence, Therapeutic Science & Strategy Unit, IQVIA, Milan, Italy.

Charles M. Rudin, MD, PhD

Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, USA

Jimmy Ruiz, MD

Department of Medicine (Hematology & Oncology), Wake Forest School of Medicine, Winston-Salem; W.G. (Bill) Hefner Veteran Administration Medical Center, Cancer Center, Salisbury, North Carolina, USA

Manuel Salto-Tellez, MD-LMS, FRCPath, FRCPI

Chair, Molecular Pathology at Queen’s University Belfast (QUB) Director, QUB’s Precision Medicine Centre of Excellence, Belfast, UK

Giorgio Vittorio Scagliotti, MD, PhD

Chief of the Medical Oncology Division at the S. Luigi Hospital, Orbassano (Torino), Head of the Department of Oncology at University of Torino, Italy

Gerald Schmid-Bindert, MD

Department of Surgery, Heidelberg University Medical Center Mannheim, Mannheim, Germany

Suresh Senan, MRCP, FRCR, PhD

Department of Radiation Oncology, University Medical Center, Amsterdam, The Netherlands

Yoshihisa Shimada, MD, PhD.

Department of Thoracic Surgery, Tokyo Medical University, Nishishinjuku, Shinjuku-ku, Tokyo, Japan

Vani Nath Simmons, PhD

Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, Florida; Department of Psychology, University of South Florida, Tampa, Florida; Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA

Ben J. Slotman, MD, PhD

Professor and Chairman, Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands

Giulia M. Stella, MD, PhD

Department of Hematological, Pneumological and Cardiovascular Sciences - Section of Pneumology, University and Fondazione IRCCS Policlinico, Pavia, Italy

Albrecht Stenzinger

Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Heidelberg, and German Cancer Research Center (DKFZ), Heidelberg, Germany

Thomas E. Stinchcombe

Thoracic Oncology Program, Duke University, Durham NC

Emily Stone

Consultant Respiratory Physician and Acting Head of Thoracic Medicine within the Department of Lung Transplantation and Thoracic Medicine at St Vincent’s Hospital, Sydney, Australia

Stephen G. Swisher

Head, Division of Surgery, Professor and Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, Department of Thoracic & Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center,Houston, TX, USA

Masayuki Takeda, MD, PhD

Professor, Department of Cancer Genomics and Medical Oncology, Nara Medical University, Nara, Japan

Nagio Takigawa, MD, PhD

Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan

Min Tao

Department of Oncology, First Affiliated Hospital of Suzhou University, Suzhou, China

Marcello Tiseo

Medical Oncology Unit, University Hospital of Parma, Parma, Italy

Gouji Toyokawa

Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan

Peter Ujhazy, MD, PhD

Deputy Associate Director, Translational Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, USA

Hidetaka Uramoto, MD, PhD

Second Department of Surgery (chest surgery), School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Japan

Paul Jules Van Houtte

Department Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium

Paul van Schil, MD

Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium

Nico van Zandwijk, MD

Asbestos Diseases Research Institute, University of Sydney Bernie Banton Centre, Concord, New South Wales, Australia

Alain Vergnenegre, MD, PhD

Service de l’Information Médicale et de l’Evaluation, Service de Pathologie Respiratoire et d’Allergologie, CHU Dupuytren, Limoges Cedex, France

Heather A. Wakelee, MD (Medical Oncology)

Department of Medical Oncology, Stanford Cancer Institute, Stanford, California, USA

Jie Wang

Department of Internal Medicine, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China

Zhehai Wang

Department of Internal Medicine-Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China

Kenneth D. Ward, PhD

School of Public Health, University of Memphis, Memphis TN, USA

Graham Warren MD, PhD

Associate Professor, Vice Chairman for Research in Radiation Oncology, Department of Radiation Oncology, Department of Cell and Molecular, Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, USA